Charlotta Eriksson-All

Goeteborg, O, Sweden

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Survival and Quality of Life After Isolated Hepatic Perfusion With Melphalan as a Treatment for Uveal Melanoma Liver Metastases: Final Results From the Phase III Randomized Controlled Trial SCANDIUM.

Survival and Quality of Life After Isolated Hepatic Perfusion With Melphalan as a Treatment for Uveal Melanoma Liver Metastases: Final Results From the Phase III Randomized Controlled Trial SCANDIUM.

Journal: Annals of surgery

Published: February 29, 2024

BAP1 genetic testing among melanoma and cancer-prone families in Sweden.

BAP1 genetic testing among melanoma and cancer-prone families in Sweden.

Journal: Acta oncologica (Stockholm, Sweden)

Published: June 02, 2023

Isolated Hepatic Perfusion With Melphalan for Patients With Isolated Uveal Melanoma Liver Metastases: A Multicenter, Randomized, Open-Label, Phase III Trial (the SCANDIUM Trial).

Isolated Hepatic Perfusion With Melphalan for Patients With Isolated Uveal Melanoma Liver Metastases: A Multicenter, Randomized, Open-Label, Phase III Trial (the SCANDIUM Trial).

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: March 20, 2023

MYCN induces cell-specific tumorigenic growth in RB1-proficient human retinal organoid and chicken retina models of retinoblastoma.

MYCN induces cell-specific tumorigenic growth in RB1-proficient human retinal organoid and chicken retina models of retinoblastoma.

Journal: Oncogenesis

Published: March 10, 2022

The PEMDAC phase 2 study of pembrolizumab and entinostat in patients with metastatic uveal melanoma.

The PEMDAC phase 2 study of pembrolizumab and entinostat in patients with metastatic uveal melanoma.

Journal: Nature communications

Published: March 28, 2021

Travel burden and clinical presentation of retinoblastoma: analysis of 1024 patients from 43 African countries and 518 patients from 40 European countries.

Travel burden and clinical presentation of retinoblastoma: analysis of 1024 patients from 43 African countries and 518 patients from 40 European countries.

Journal: The British journal of ophthalmology

Published: April 29, 2020

Global Retinoblastoma Presentation and Analysis by National Income Level.

Global Retinoblastoma Presentation and Analysis by National Income Level.

Journal: JAMA oncology

Published: February 28, 2020

Molecular profiling of driver events in metastatic uveal melanoma.

Molecular profiling of driver events in metastatic uveal melanoma.

Journal: Nature communications

Published: July 02, 2019

Concomitant use of pembrolizumab and entinostat in adult patients with metastatic uveal melanoma (PEMDAC study): protocol for a multicenter phase II open label study.

Concomitant use of pembrolizumab and entinostat in adult patients with metastatic uveal melanoma (PEMDAC study): protocol for a multicenter phase II open label study.

Journal: BMC cancer

Published: November 19, 2018

Ruthenium-106 versus iodine-125 plaque brachytherapy of 571 choroidal melanomas with a thickness of ≥5.5 mm.

Ruthenium-106 versus iodine-125 plaque brachytherapy of 571 choroidal melanomas with a thickness of ≥5.5 mm.

Journal: The British journal of ophthalmology

Published: October 22, 2018

Intra-arterial chemotherapy for retinoblastoma in Sweden - evaluation of treatment efficacy and complications.

Intra-arterial chemotherapy for retinoblastoma in Sweden - evaluation of treatment efficacy and complications.

Journal: Acta ophthalmologica

Published: April 25, 2018

Melanoma in places other than the skin: eye and mucous membrane melanomas

Melanoma in places other than the skin: eye and mucous membrane melanomas

Journal: Lakartidningen

Published: May 10, 2017

Showing 1-12 of 13

Last Updated: 09/26/2026